Table 1. Demographic and clinical features of the participants.

	Exercise group (28)	Non-exercise group (24)	Control group (30)
Age	68.21 ± 5.07	68.46 ± 4.40	66 ± 4.89
Male: Female	9:19	10:14	13:17
Educational level	13 ± 2.62	11.95 ± 2.54	12.43 ± 2.33
MoCA	27.18 ± 1.52	26.25 ± 2.13	27.03 ± 1.47
UPDRS-III	16 ± 6.88	25 ± 12.58	/
Levodopa (mg)	270.09 ± 149.32	359.38 ± 187.27	/
Duration of disease	6.45 ± 3.65	5.58 ± 3.87	/
Hoehn & Yahr stage	1.16 ± 0.36	1.29 ± 0.44	/

Notes.

MoCA

Montreal Cognitive Assessment

UPDRS-III

Unified Parkinson’s Disease Rating Scale part III